Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome
Abstract Background Polycystic ovary syndrome (PCOS) is a complex condition with high risk for dyslipidemia, dysglycemia, venous thromboembolism, cardiovascular disease and metabolic syndrome. Because the combined oral contraceptive (COC) use has also been associated with impaired fasting glucose, i...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | Reproductive Biology and Endocrinology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12958-017-0313-y |